1. Abbott R, Ayres I (2014) Evidence and extrapolation: mechanisms for regulating off-label uses of drugs and devices. Duke Law J 64(3):377–435
2. ANSM (AgenceNationale de Sécurité du Médicament et des Produits de Santé) (2012) Temporary Recommendation for Use (RTUs) Principles and information on the methods used by the ANSM for establishment and implementation, available at ansm.sante.fr/content/download/.../RTU-english.pdf (last visited March 6, 2018)
3. Ask, M (2014) Drug Companies Oppose Moves to Reimburse Off-Label Medicine, The Wall Street Journal, available at at http://www.wsj.com/articles/drug-companies-oppose-moves-to-reimburse-off-label-medicine-1406287000 (last visited December 14, 2017)
4. Banzi R, Gerardi C, Bertele V, Garattini S (2015) Approvals of drugs with uncertain benefit–risk profiles in Europe. Eur J Intern Med 26:572–584
5. Barrios Flores LF (2014) Responsabilidad por Uso Compasivo y Off-Label de Medicamentos. DS: Derecho y Salud 24(1):28–49